Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
703 studies found for:    Burkitt's Lymphoma
Show Display Options
Rank Status Study
1 Terminated
Has Results
Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma
Conditions: Burkitt Lymphoma;   Non-Hodgkins Lymphoma;   Atypical Burkitt Lymphoma
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Methotrexate;   Drug: Leucovorin;   Drug: Ifosfamide;   Drug: Etoposide;   Drug: Cytarabine;   Drug: Mesna
2 Recruiting Epidemiology of Burkitt Lymphoma in East Africa Children or Minors (EMBLEM)
Conditions: Lymphoma, Non-Hodgkin;   Malaria;   Herpesvirus 4, Human
Intervention:
3 Active, not recruiting Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
Conditions: Burkitt Lymphoma;   Diffuse Large B-cell Lymphoma, c-MYC Positive;   Plasmablastic Lymphoma
Interventions: Drug: EPOCH-R;   Drug: EPOCH-RR
4 Unknown  Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma
Conditions: HIV;   Burkitt's Lymphoma
Interventions: Drug: Induction Phase;   Drug: Consolidation Phase (on day +50);   Drug: Intensification phase;   Drug: BEAM conditioning;   Radiation: Consolidation radiotherapy
5 Completed Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma
Conditions: Burkitt Lymphoma;   B-ALL
Intervention: Drug: Chemotherapy-Rituximab combination
6 Completed Rituximab Combined With Chemotherapy in Burkitt`s Lymphoma
Conditions: Acute Lymphoblastic Leukemia;   Burkitt's Lymphoma
Intervention: Drug: RITUXIMAB
7 Completed Retrospective Analysis of Rituximab-containing Immunochemotherapy for Burkitt's or Burkitt-like Lymphoma in Adults
Conditions: Burkitt's Lymphoma;   High-grade B-cell Lymphoma
Intervention: Other: No intervention (observational study)
8 Completed Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL
Conditions: Non-Hodgkin Lymphoma;   Acute Lymphoblastic Leukemia, Mature B-Cell
Intervention: Drug: Prednison, Vincristine, Cytarabine, Methotrexate, Etoposide, Cyclophosphamide, Doxorubicin
9 Unknown  LMBA02 Protocol for Patients With a Burkitt Lymphoma
Condition: Burkitt Lymphoma
Intervention: Drug: rituximab
10 Completed
Has Results
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Biological: pegfilgrastim;   Biological: rituximab;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: leucovorin calcium;   Drug: liposomal cytarabine;   Drug: methotrexate;   Drug: therapeutic hydrocortisone;   Drug: vincristine sulfate
11 Recruiting Burkitt Leukemia - Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Ofatumumab (EPOCH - O)
Condition: Leukemia
Interventions: Drug: Ofatumumab;   Drug: Etoposide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Cyclophosphamide;   Drug: Prednisone;   Drug: Rituximab;   Drug: Pegfilgrastim;   Drug: G-CSF;   Behavioral: Phone Calls
12 Completed
Has Results
Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
Conditions: Leukemia;   Lymphoma
Interventions: Biological: filgrastim;   Biological: rituximab;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: prednisone;   Drug: vincristine sulfate;   Drug: Allopurinol
13 Completed Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia
Condition: B-cell Acute Lymphoblastic Leukemia
Intervention: Drug: forodesine hydrochloride (BCX-1777)
14 Recruiting The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL).
Condition: B-cell Acute Lymphoblastic Leukemia
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: CART-19 cells
15 Withdrawn Study Evaluating the Efficacy of 90Yttrium-epratuzumab in Adults With CD22+ Relapsed/Refractory B-ALL
Condition: CD22+ Relapsed/Refractory B-ALL
Interventions: Drug: 90Y-epratuzumab tetraxetan;   Drug: chemotherapy/ immunotherapy
16 Active, not recruiting Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
Conditions: Leukemia;   Acute Lymphoblastic Leukemia
Intervention: Biological: gene-modified T cells targeted
17 Recruiting Dose Escalation Study of UCART19 in Adult Patients With Relapsed / Refractory B-cell Acute Lymphoblastic Leukaemia
Condition: B-cell Acute Lymphoblastic Leukemia
Intervention: Genetic: UCART19
18 Recruiting Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk
Condition: B-cell Acute Lymphoblastic Leukemia
Intervention:
19 Active, not recruiting T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Condition: Relapsed B-Cell Acute Lymphoblastic Leukemia
Interventions: Procedure: leukapheresis or collection of PBMCs;   Drug: cyclophosphamide based chemotherapy regimens;   Biological: modified T cells
20 Terminated Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL
Condition: Burkitt Lymphoma
Intervention: Drug: Rituximab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.